MHC class I: an unexpected role in neuronal plasticity.
Level 5 - mechanism / opinion, no new human data
Narrative review or commentary discussing mechanism-based research with no primary human data reported
PubMed 19840547 · doi:10.1016/j.neuron.2009.09.044
What was done
The author summarizes accumulated evidence examining the non-canonical role of major histocompatibility complex class I (MHCI) molecules in mediating structural synaptic plasticity during critical periods of activity-dependent neural development.
What was found
The abstract reports no numerical values, sample sizes, or quantitative outcomes. It highlights the qualitative finding that MHCI proteins are involved in the lasting structural changes at synapses necessary to convert experience into behavior and memory.
Why it matters
This work outlines a functional crossover between classical immune-system recognition molecules and fundamental neurobiological processes regulating synaptic remodeling.
Limits
The abstract provides no primary empirical data, experimental metrics, or detailed methodology. As a conceptual overview or review, it does not detail sample sizes, specific model systems, or effect sizes.
Cited by
- supports Major histocompatibility complex (MHC) molecules and immune cells are actively functional throughout the lifespan within the central nervous system.